Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

P-BEAM: Biosimilars Educational Advanced Masterclass for Pharmacists

5 - 6 Sep 2019

Hilton Zurich Airport, Zurich, Switzerland

Assessing biosimilars in the real world setting

Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands

Assessing biosimilars in the real world setting ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )

Practical guidance on the assessment of biosimilar monoclonal antibodies: A...

Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands

Practical guidance on the assessment of biosimilar monoclonal antibodies: A pharmacist's perspective ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )

Effective communication about biosimilars

Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands

Effective communication about biosimilars ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )

The role of the pharmacist in supporting multi-disciplinary education

Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands

The role of the pharmacist in supporting multi-disciplinary education ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )

Realising the potential of biosimilars

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Immunogenicity of biosimilars

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Critical quality attributes of biosimilars

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Critical quality attributes of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Use of biosimilar monoclonal antibodies in the clinic

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Supporting a sustainable biosimilar solution

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Practical considerations for introducing biosimilars

Simon Cheesman - University College Hospital, London, UK

Practical considerations for introducing biosimilars ( Simon Cheesman - University College Hospital, London, UK )

Successful implementation of biosimilars through effective communication

Dr Pauline Leonard - The Whittington Hospital, London, UK

Successful implementation of biosimilars through effective communication ( Dr Pauline Leonard - The Whittington Hospital, London, UK )

How real-world data generation can assist biosimilar implementation

Simon Cheesman - University College Hospital, London, UK

How real-world data generation can assist biosimilar implementation ( Simon Cheesman - University College Hospital, London, UK )

Regulatory principles for biosimilar medicines

Prof Paul Declerck - KU Leuven, Leuven, Belgium

Regulatory principles for biosimilar medicines ( Prof Paul Declerck - KU Leuven, Leuven, Belgium )

Biologics utilisation and its efficiency through a hospital pharmacy...

Jose Feio - University of Coimbra, Coimbra, Portugal

Biologics utilisation and its efficiency through a hospital pharmacy centralised management system ( Jose Feio - University of Coimbra, Coimbra, Portugal )

The science of biosimilarity: Immunogenicity

Prof João Gonçalves - University of Lisbon, Lisbon, Portugal

The science of biosimilarity: Immunogenicity ( Prof João Gonçalves - University of Lisbon, Lisbon, Portugal )

Introduction of the biosimilar trastuzumab and its impact on patients and...

Geoff Saunders - The Christie NHS Foundation Trust, Manchester, UK

Introduction of the biosimilar trastuzumab and its impact on patients and services ( Geoff Saunders - The Christie NHS Foundation Trust, Manchester, UK )

Practical guidance on the assessment of biosimilar monoclonal antibodies: A...

Prof Diana Lüftner - Charité University Hospital, Berlin, Germany

Practical guidance on the assessment of biosimilar monoclonal antibodies: A physician's perspective ( Prof Diana Lüftner - Charité University Hospital, Berlin, Germany )

More from ecancer